Quick Answer
Connect Biopharma Holdings Ltd reported Stockholders Equity of $41.98 million for fiscal year 2025.
Connect Biopharma Holdings Ltd Stockholders Equity — Annual History
| Fiscal Year | Stockholders Equity | YoY Change |
|---|---|---|
| 2025 | $41.98M | -54.5% |
| 2024 | $92.17M | -9.2% |
| 2023 | $101.50M | -35.9% |
| 2022 | $158.42M | — |
Quarterly Stockholders Equity
| Quarter Ending | Stockholders Equity | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $55.37M | -45.0% | -22.4% |
| June 30, 2025 | $71.34M | -35.7% | -13.9% |
| March 31, 2025 | $82.90M | -11.7% | -10.1% |
| December 31, 2024 | $92.17M | -9.2% | -8.4% |
| September 30, 2024 | $100.65M | — | -9.3% |
| June 30, 2024 | $110.93M | — | +18.1% |
| March 31, 2024 | $93.89M | — | -7.5% |
| December 31, 2023 | $101.50M | — | — |
- Connect Biopharma Holdings Ltd showed a decrease of -54.5% in Stockholders Equity compared to the prior fiscal year.
- Over the 2022–2025 period, Connect Biopharma Holdings Ltd’s stockholders equity has declined by 73.5% (from $158.42 million to $41.98 million).
- The most recent figure is from Connect Biopharma Holdings Ltd’s fiscal year 2025 report (Form 10-K), filed with the SEC on March 31, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: